NCT04548752 · Interventional trial
Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations
Overall registry status Active not recruiting
Phase 2
Conditions Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8
Delaware Valley sites
- University of Pennsylvania/Abramson Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory